PILIANIDIS, G.; PAPANASTASIOU, G. .; TIKOUDI, P. .; THEMISTOCLEOUS, A. .; FARMAKIS, G. .; DOLIANITIS, K. . Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?. European Journal of Case Reports in Internal Medicine, [S. l.], v. 11, n. 3, 2024. DOI: 10.12890/2024_004282. Disponível em: https://www.ejcrim.com/index.php/EJCRIM/article/view/4282. Acesso em: 18 apr. 2024.